$1.35
-0.03 (-2.17%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,220.0% upside
Low Target
$21.60
Average Target
$31.32
High Target
$37.71
Current Price
$1.35
Current
$1.35
$1.35
Target
$31.32
$31.32
$21.60
$31.32 avg
$37.71
Scenario Analysis
Bear Case
$21.60
1,500.0%
Low target
Base Case
$31.32
+2,220.0%
Avg target
Bull Case
$37.71
+2,693.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.23
-39.5% from high
52-Week Low
$0.85
+58.8% from low
Target vs 52W High
$31.32
+1,304.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.9% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |